VELOSEF Drug Patent Profile
When do Velosef patents expire, and when can generic versions of Velosef launch?
Velosef is a drug marketed by Apothecon, Bristol Myers Squibb, and Ersana. and is included in five NDAs.
The generic ingredient in VELOSEF is cephradine. There is one drug master file entry for this compound. Additional details are available on the cephradine profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for VELOSEF?
- What are the global sales for VELOSEF?
- What is Average Wholesale Price for VELOSEF?
Summary for VELOSEF
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 5 |
| Raw Ingredient (Bulk) Api Vendors: | 71 |
| Patent Applications: | 7,256 |
| DailyMed Link: | VELOSEF at DailyMed |
US Patents and Regulatory Information for VELOSEF
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apothecon | VELOSEF | cephradine | CAPSULE;ORAL | 061764-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Apothecon | VELOSEF | cephradine | INJECTABLE;INJECTION | 061976-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Apothecon | VELOSEF | cephradine | INJECTABLE;INJECTION | 061976-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ersana | VELOSEF '500' | cephradine | CAPSULE;ORAL | 050548-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Bristol Myers Squibb | VELOSEF | cephradine | TABLET;ORAL | 050530-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
